Genicular Nerve Block Versus Its Combination With Infiltration Between Popliteal Artery and Capsule of Posterior Knee
1 other identifier
interventional
63
1 country
1
Brief Summary
Comparison of the analgesic and physical recovery effect of genicular nerve block (GNB) alone and (GNB + infiltration between popliteal artery and posterior capsule of the knee (IPACK) in patients undergoing total knee replacement
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable postoperative-pain
Started Nov 2022
Longer than P75 for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2022
CompletedStudy Start
First participant enrolled
November 5, 2022
CompletedFirst Posted
Study publicly available on registry
January 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedNovember 26, 2024
November 1, 2024
2.1 years
November 5, 2022
November 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
2 hours visual analogue scale
pain intensity at rest and with motion using visual analogue scale from " horizontal line of 10-cm long with two ends, one end indicate no pain 0 and the other end indicate worst pain 10".
at 2 hour postoperative.
4 hours visual analogue score
pain intensity at rest and with motion using visual analogue scale from " horizontal line of 10-cm long with two ends, one end indicate no pain 0 and the other end indicate worst pain 10".
at 4 hours postoperative
6 hours visual analogue score
pain intensity at rest and with motion using visual analogue scale from " horizontal line of 10-cm long with two ends, one end indicate no pain 0 and the other end indicate worst pain 10".
at 6 hours postoperative
8 hours visual analogue score
pain intensity at rest and with motion using visual analogue scale from " horizontal line of 10-cm long with two ends, one end indicate no pain 0 and the other end indicate worst pain 10".
at 8 hours postopertaive
12 hours visual analogue score
pain intensity at rest and with motion using visual analogue scale from " horizontal line of 10-cm long with two ends, one end indicate no pain 0 and the other end indicate worst pain 10".
at 12 hours postoperative
18 hours visual analogue score
pain intensity at rest and with motion using visual analogue scale from " horizontal line of 10-cm long with two ends, one end indicate no pain 0 and the other end indicate worst pain 10".
at 18 hours postoperative
24 hours visual analogue score
pain intensity at rest and with motion using visual analogue scale from " horizontal line of 10-cm long with two ends, one end indicate no pain 0 and the other end indicate worst pain 10".
at 24 hours postoperative
Secondary Outcomes (7)
• Time of performance of block
from putting of U.S probe till the end of block procedure
• Total morphine consumption
at 24 hours post-operatively
•incidence of Anticipated side effect
at 24,48 hours postoperative
degree of maximum active flexion and extension of the knee
at 24 hours post operative
walk test
at 24 hours post operative
- +2 more secondary outcomes
Study Arms (3)
C group
ACTIVE COMPARATORthe patients will take standard analgesia ( meloxicam (15 mg) once a day + paracetamol 1gm /3 times a day). ,with no nerve block
G group
ACTIVE COMPARATORthe patients will take standard analgesia plus GNB
GI group
ACTIVE COMPARATORthe patients will take standard analgesia plus GNB plus IPACK
Interventions
When patients are in supine position with a pillow under the popliteal fossa, we will target points next to superior medial, superior lateral, and inferior medial genicular arteries to block the superior medial, superior lateral, and inferior medial branches of genicular nerve. For identification, we will use color Doppler near the periosteal areas (the junctions of the epicondyle with the shafts of the femur and tibia, accordingly). using a 12 MHz linear transducer (XarioTM SSA-660A, Toshiba Medical Systems Corporation, Otawara, Japan) positioned parallel to the shaft of the long bones in the legs, the needle will be inserted ( in plane technique in the long-axis view) and a 2.5 mL of bupivacaine (5%) will be injected at each target points.standard analgesia will be given post-operativelly (paracetamol 1 gm/ three times a daily and meloxicam (15 mg)once a day)
IPACK block will be done when the patients in supine position with the knee flexed in 45 degree. using a low frequency transducer at a depth of 3.5-4 cm positioned transversely, 2-3 cm above the patella and over the medial aspect of the knee, we will identify the distal part of the shaft of the femur and the popliteal artery with sliding the transducer proximally and distally (If the two femoral condyles appear first, proximal sliding of the probe, so the humps of the femoral condyles will disappeared and the flat metaphysis will appeared). With advancement of the needle in plane toward the space between the popliteal artery and the femur, 15 ml of bupivacaine 0.5% will be injected. The genicular nerve block will be done as in group G and standard analgesia will be given post-operative as in group G
(paracetamol 1 gm 3 times a daily and meloxicam (15 mg) once aday.
Eligibility Criteria
You may qualify if:
- Adult patients aged between 21 to 60 years
- undergoing primary unilateral elective total knee arthroplasty under spinal anesthesia
- Having informed consents
- patients with physical status ASA I \& II
- both genders
- body mass index less than 40 kg/m2.
You may not qualify if:
- patients with Peripheral vascular disease
- patients with history of allergy to local anesthesia or opioid analgesia,
- those on anti-platelet, anticoagulant or B blocker drugs
- Patients with acute decompensated heart failure
- Patients with hypertension
- Patients with heart block
- Patients with coronary disease
- Patients with bronchial asthma
- Patients with bleeding disorders
- Patients with compromised renal or hepatic function
- pregnant female.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Heba M Fathi
Zagazig, Egypt
Related Publications (1)
Fathi HM, Fahmy AM, Shaker MA, Kamel AAF. Comparison of genicular nerve block and its combination with IPACK block for analgesia and recovery after total knee arthroplasty: a randomized trial. BMC Anesthesiol. 2025 Nov 29;25(1):601. doi: 10.1186/s12871-025-03408-0.
PMID: 41318369DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Heba M Fathi
Study Record Dates
First Submitted
November 5, 2022
First Posted
January 5, 2023
Study Start
November 5, 2022
Primary Completion
December 5, 2024
Study Completion
December 30, 2024
Last Updated
November 26, 2024
Record last verified: 2024-11